Coursera shares rise despite analyst downgrades and mixed market
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 13 2024
0mins
Should l Buy COUR?
Coursera's shares increased by 9.47% as it crossed above the 5-day SMA, showing resilience amid a challenging market environment.
Despite a significant drop of 17% earlier this week and analysts cutting price targets due to disappointing Q2 guidance, Coursera's stock rebounded. The company's Q1 earnings report revealed a revenue of $195.7 million, slightly exceeding expectations, although it reported a net loss of $20.5 million. Analysts remain divided on the stock, with some maintaining a 'buy' rating, indicating potential for recovery despite recent setbacks.
The market's mixed performance, with the Nasdaq down 1.30%, highlights the volatility in investor sentiment. Coursera's ability to leverage its recent user growth and strategic initiatives, such as the merger with Udemy, may provide a pathway for future growth, suggesting that the stock's recent rise could be a sign of investor optimism.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COUR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COUR
Wall Street analysts forecast COUR stock price to rise
13 Analyst Rating
8 Buy
5 Hold
0 Sell
Moderate Buy
Current: 6.150
Low
9.00
Averages
12.10
High
14.00
Current: 6.150
Low
9.00
Averages
12.10
High
14.00
About COUR
Coursera, Inc. provides an online learning platform that connects learners, educators, and institutions by providing affordable and relevant educational content. It offers a range of paid offerings, including standalone courses, multi-course specializations, industry certificate programs, and university degrees. Its segments include Consumer, Enterprise, and Degrees. The Consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers. The Enterprise segment is focused on serving businesses, government organizations, and academic institutions by providing an online platform with access to job-relevant educational content enabling them to train, upskill, and reskill their employees, citizens, and students. The Degrees segment is engaged in partnering with universities to deliver fully online bachelor’s and master’s degrees.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of Coursera Stock Investment Prospects
- Valuation Appeal: Coursera's current share price of $6.35 and a P/E ratio of 14.43 indicate that its valuation in the ed-tech sector is undervalued, despite the market significantly discounting its medium-term earnings potential, suggesting a rebound opportunity.
- Fundamental Improvement: The company is experiencing accelerating revenue growth, positive cash flow, and improving margins, indicating a clearer path to profitability, with intrinsic value estimates around $11.45 per share, implying substantial upside potential.
- Technical Recovery: Technical indicators show that the stock's RSI is beginning to recover, with the Money Flow Index crossing above 50, suggesting that buyers are gradually re-entering the market, which may signal a trend reversal and boost investor confidence.
- AI-Driven Growth: Coursera benefits from surging global demand for generative AI and data science courses, as management shifts focus towards high-quality, scalable revenue streams, further enhancing its market competitiveness and financial stability.
See More
Investigation into Coursera Investor Claims
- Financial Performance Disclosure: Coursera reported Q1 2026 revenue of $195.7 million, a 9% year-over-year increase, yet the overall revenue outlook remains at $805 million to $815 million, with enterprise performance falling short of long-term expectations, indicating weak market demand.
- Enterprise Growth Struggles: The company disclosed enterprise revenue of $66.2 million, up 7% year-over-year, but the growth rate lags behind consumer business, reflecting ongoing pressure on enterprise demand and retention, which could impact future profitability.
- Stock Price Decline Impact: Following the disappointing performance, Coursera's stock price dropped, resulting in investor losses and prompting Johnson Fistel to investigate whether the company complied with federal securities laws to protect investor rights.
- Law Firm Involvement: Johnson Fistel is representing investors in investigating potential claims, emphasizing its expertise and success in securities class actions, having recovered approximately $90.725 million for clients in the past, showcasing its capability in advocating for investor rights.
See More
Coursera Shares Plunge 17% as Analysts Cut Price Targets
- Significant Stock Drop: Coursera's shares plummeted 17% this week, marking its worst performance in 20 months, reflecting investor disappointment over the company's Q2 guidance, which has led to a notable decline in market confidence.
- Guidance Misses Expectations: The company’s Q2 revenue guidance of $196 to $200 million slightly fell short of analyst expectations of $198 to $200 million, while the FY26 guidance was updated to $805 million to $815 million, below the anticipated $815 million, indicating uncertainty in future growth.
- Divergent Analyst Ratings: According to Koyfin, among 13 analysts, 7 rated the stock as ‘buy’, 4 as ‘hold’, and 2 as ‘sell’, highlighting a significant divergence in market sentiment regarding Coursera's future performance.
- Weak Consumer Revenue Growth: RBC Capital lowered its price target to $7, noting that consumer revenue growth missed consensus estimates, and while enterprise revenue exceeded expectations, it still faces challenges in a mixed demand environment across customer segments and regions.
See More
Coursera Shares Plunge 11.6% Following Q1 Earnings Miss
- Significant Stock Decline: Coursera's stock fell 11.6% on Friday, contrasting with the S&P 500's 0.8% gain and the Nasdaq's 1.6% rise, indicating a negative market reaction to its earnings report, resulting in a year-to-date decline of approximately 28%.
- Earnings Report Analysis: The company reported non-GAAP earnings of $0.07 per share on sales of $195.7 million for Q1, surpassing sales expectations by about $0.6 million, yet falling short of earnings expectations by $0.01, raising concerns about its pricing power amid potential disruptions from artificial intelligence.
- Market Reaction and Outlook: Despite the disappointing Q1 results, Coursera reaffirmed its guidance for annual sales between $805 million and $815 million, and achieving the midpoint would indicate a growth of roughly 7% over last year's $757 million, reflecting the stability of its customer base.
- Investor Sentiment and Opportunities: While the stock has significantly declined, analysts suggest that investors may be overreacting to the earnings report, as Coursera still has opportunities to leverage AI to adapt to competitive changes, potentially leading to a recovery in growth.
See More
Midday Market Moves: Notable Stock Fluctuations
- Comcast Downgrade: Comcast's stock fell nearly 8% after Deutsche Bank downgraded its rating from Buy to Hold, with analysts indicating that while there is visibility into sustainable revenue and EBITDA growth, they do not expect multiple expansion, highlighting challenges in a stable but non-growing business environment.
- HCA Healthcare Decline: HCA Healthcare's stock dropped over 7% due to a milder flu season resulting in fewer patient admissions, and although the company narrowly beat analyst profit estimates, investors are concerned about declining patient demand as Affordable Care Act subsidies phase out.
- Organon Surge: Organon's stock spiked 22% following a report from The Economic Times that Sun Pharma plans to submit a $13 billion offer for the U.S.-based company, which could significantly enhance Organon's market value and investor confidence.
- Intel Earnings Beat: Intel reported first-quarter earnings of 29 cents per share on revenue of $13.58 billion, both exceeding Wall Street expectations, leading to a stock rally of over 23%, indicating a strong recovery momentum in the semiconductor market that may boost overall industry investment enthusiasm.
See More
Wall Street Futures Mixed Amid U.S.-Iran Stalemate and Earnings Reports
- Mixed Market Performance: Wall Street futures showed mixed performance on Friday, with S&P 500 E-minis flat, Nasdaq 100 E-minis up 0.60%, and Dow E-minis down 0.36%, reflecting investor caution amid geopolitical tensions.
- Geopolitical Impact: President Trump unilaterally extended the ceasefire with Iran while maintaining the naval blockade of Iranian ports, leading to diminished confidence in future negotiations and weakening investor expectations for lasting progress.
- Earnings Resilience: Despite strong earnings reports from several companies, some investors question their reliability as they reflect only one month of war disruption, potentially failing to provide an accurate outlook for future trends.
- Oil Price Volatility: Brent crude futures remain 47% above pre-war levels due to disruptions in the crucial Strait of Hormuz shipping route, making oil price uncertainty a significant market risk, although some investors view the current pullback as a buying opportunity.
See More
Analysis of Coursera Stock Investment Prospects
- Valuation Appeal: Coursera's current share price of $6.35 and a P/E ratio of 14.43 indicate that its valuation in the ed-tech sector is undervalued, despite the market significantly discounting its medium-term earnings potential, suggesting a rebound opportunity.
- Fundamental Improvement: The company is experiencing accelerating revenue growth, positive cash flow, and improving margins, indicating a clearer path to profitability, with intrinsic value estimates around $11.45 per share, implying substantial upside potential.
- Technical Recovery: Technical indicators show that the stock's RSI is beginning to recover, with the Money Flow Index crossing above 50, suggesting that buyers are gradually re-entering the market, which may signal a trend reversal and boost investor confidence.
- AI-Driven Growth: Coursera benefits from surging global demand for generative AI and data science courses, as management shifts focus towards high-quality, scalable revenue streams, further enhancing its market competitiveness and financial stability.
See More
Investigation into Coursera Investor Claims
- Financial Performance Disclosure: Coursera reported Q1 2026 revenue of $195.7 million, a 9% year-over-year increase, yet the overall revenue outlook remains at $805 million to $815 million, with enterprise performance falling short of long-term expectations, indicating weak market demand.
- Enterprise Growth Struggles: The company disclosed enterprise revenue of $66.2 million, up 7% year-over-year, but the growth rate lags behind consumer business, reflecting ongoing pressure on enterprise demand and retention, which could impact future profitability.
- Stock Price Decline Impact: Following the disappointing performance, Coursera's stock price dropped, resulting in investor losses and prompting Johnson Fistel to investigate whether the company complied with federal securities laws to protect investor rights.
- Law Firm Involvement: Johnson Fistel is representing investors in investigating potential claims, emphasizing its expertise and success in securities class actions, having recovered approximately $90.725 million for clients in the past, showcasing its capability in advocating for investor rights.
See More
Coursera Shares Plunge 17% as Analysts Cut Price Targets
- Significant Stock Drop: Coursera's shares plummeted 17% this week, marking its worst performance in 20 months, reflecting investor disappointment over the company's Q2 guidance, which has led to a notable decline in market confidence.
- Guidance Misses Expectations: The company’s Q2 revenue guidance of $196 to $200 million slightly fell short of analyst expectations of $198 to $200 million, while the FY26 guidance was updated to $805 million to $815 million, below the anticipated $815 million, indicating uncertainty in future growth.
- Divergent Analyst Ratings: According to Koyfin, among 13 analysts, 7 rated the stock as ‘buy’, 4 as ‘hold’, and 2 as ‘sell’, highlighting a significant divergence in market sentiment regarding Coursera's future performance.
- Weak Consumer Revenue Growth: RBC Capital lowered its price target to $7, noting that consumer revenue growth missed consensus estimates, and while enterprise revenue exceeded expectations, it still faces challenges in a mixed demand environment across customer segments and regions.
See More
Coursera Shares Plunge 11.6% Following Q1 Earnings Miss
- Significant Stock Decline: Coursera's stock fell 11.6% on Friday, contrasting with the S&P 500's 0.8% gain and the Nasdaq's 1.6% rise, indicating a negative market reaction to its earnings report, resulting in a year-to-date decline of approximately 28%.
- Earnings Report Analysis: The company reported non-GAAP earnings of $0.07 per share on sales of $195.7 million for Q1, surpassing sales expectations by about $0.6 million, yet falling short of earnings expectations by $0.01, raising concerns about its pricing power amid potential disruptions from artificial intelligence.
- Market Reaction and Outlook: Despite the disappointing Q1 results, Coursera reaffirmed its guidance for annual sales between $805 million and $815 million, and achieving the midpoint would indicate a growth of roughly 7% over last year's $757 million, reflecting the stability of its customer base.
- Investor Sentiment and Opportunities: While the stock has significantly declined, analysts suggest that investors may be overreacting to the earnings report, as Coursera still has opportunities to leverage AI to adapt to competitive changes, potentially leading to a recovery in growth.
See More
Midday Market Moves: Notable Stock Fluctuations
- Comcast Downgrade: Comcast's stock fell nearly 8% after Deutsche Bank downgraded its rating from Buy to Hold, with analysts indicating that while there is visibility into sustainable revenue and EBITDA growth, they do not expect multiple expansion, highlighting challenges in a stable but non-growing business environment.
- HCA Healthcare Decline: HCA Healthcare's stock dropped over 7% due to a milder flu season resulting in fewer patient admissions, and although the company narrowly beat analyst profit estimates, investors are concerned about declining patient demand as Affordable Care Act subsidies phase out.
- Organon Surge: Organon's stock spiked 22% following a report from The Economic Times that Sun Pharma plans to submit a $13 billion offer for the U.S.-based company, which could significantly enhance Organon's market value and investor confidence.
- Intel Earnings Beat: Intel reported first-quarter earnings of 29 cents per share on revenue of $13.58 billion, both exceeding Wall Street expectations, leading to a stock rally of over 23%, indicating a strong recovery momentum in the semiconductor market that may boost overall industry investment enthusiasm.
See More
Wall Street Futures Mixed Amid U.S.-Iran Stalemate and Earnings Reports
- Mixed Market Performance: Wall Street futures showed mixed performance on Friday, with S&P 500 E-minis flat, Nasdaq 100 E-minis up 0.60%, and Dow E-minis down 0.36%, reflecting investor caution amid geopolitical tensions.
- Geopolitical Impact: President Trump unilaterally extended the ceasefire with Iran while maintaining the naval blockade of Iranian ports, leading to diminished confidence in future negotiations and weakening investor expectations for lasting progress.
- Earnings Resilience: Despite strong earnings reports from several companies, some investors question their reliability as they reflect only one month of war disruption, potentially failing to provide an accurate outlook for future trends.
- Oil Price Volatility: Brent crude futures remain 47% above pre-war levels due to disruptions in the crucial Strait of Hormuz shipping route, making oil price uncertainty a significant market risk, although some investors view the current pullback as a buying opportunity.
See More
